Search references for MITAPIVAT. Phrases containing MITAPIVAT
See searches and references containing MITAPIVAT!MITAPIVAT
Chemical compound
Mitapivat, sold under the brand name Pyrukynd among others, is a medication used to treat different types of anemia. It is taken as the sulfate hydrate
Mitapivat
Public American pharmaceutical company
$256 million aggregate gross proceeds. In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with
Agios_Pharmaceuticals
Reduced oxygen-carrying ability of the blood due to breakdown of red blood cells
(i.e., most of the red blood cells are being removed by the spleen). Mitapivat was approved for medical use in the United States in February 2022. Hemolytic
Hemolytic_anemia
Pharmaceutical drug classification
Crizanlizumab B06AX02 Betibeglogene autotemcel B06AX03 Voxelotor B06AX04 Mitapivat B06AX05 Exagamglogene autotemcel B06AX06 Lovotibeglogene autotemcel B06AX07
ATC_code_B06
Lebanese hematologist
increasing hemoglobin production. In 2025, Taher led a global phase 3 trial of mitapivat, a potential oral treatment for non-transfusion-dependent thalassemia
Ali_T._Taher
Medical condition
spleen. This reduces severe anemia and the need for blood transfusions.Mitapivat was approved for medical use in the United States in February 2022. Pyruvate
Pyruvate_kinase_deficiency
mirvetuximab soravtansine (INN) misonidazole (INN) misoprostol (INN) mitapivat (INN) mitapivat sulfate (USAN) mitemcinal fumarate (USAN) Mithracin (Pfizer) mitiglinide
List_of_drugs:_Meu–Mi
travel, tourism, insurance
MITAPIVAT
MITAPIVAT
MITAPIVAT
MITAPIVAT
MITAPIVAT
MITAPIVAT
MITAPIVAT
MITAPIVAT
MITAPIVAT
travel, tourism, insurance